At Harbinger Health, our mission is to change the cancer paradigm by taking a proactive approach to cancer detection and prevention. We envision a future where cancer is no longer a life-altering event, but a routine health problem that can be addressed with early intervention. To achieve this, we have developed proprietary solutions for cancer pre-emption, starting with blood-based tests that can detect cancer before it even becomes visible. By identifying biological programs that are the root cause of cancer, we can enable early-stage and pre-disease identification, leading to truly personalized and effective cancer care for everyone. With Harbinger Health leading the way, we believe that a cancer-free future is not only possible but within reach, for everyone.
-
Industry
-
Biotechnology Research
-
Company size
-
51-200 employees
-
Headquarters
-
Cambridge, MA
-
Type
-
Privately Held
-
Founded
-
2021
-
Specialties
-
MCED, Cancer, cancer prevention, cancer education, oncology, and early cancer detection